Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sequential, Open-Label Study of the Pharmacokinetics and Safety of Intravenous Carbamazepine Relative to Oral Carbamazepine in Adult Patients With Epilepsy

NCT01079351 is registered in ClinicalTrials.gov with Lundbeck LLC as lead sponsor.

NCT NCT01079351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01079351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sequential, Open-Label Study of the Pharmacokinetics and Safety of Intravenous Carbamazepine Relative to Oral Carbamazepine in Adult Patients With Epilepsy
Lead sponsor
Lundbeck LLC
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2007
Completion date
April 30, 2009
Enrollment
98 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy